Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan To Its Board Of Directors
(MENAFN- PR Newswire) WALTHAM, Mass., May 15, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE ) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, …